RELATED CONTENT
NEWS
- NICE no for Tyverb and Herceptin in breast cancer, Roche considers appeal
- NICE says no to GSK's Tyverb and Roche's Herceptin, again
- NICE still down on overall survival benefit of Roche's Herceptin and GSK's Tyverb following appeal
- Takeda REACTs to NICE request for another Daxas trial
ANALYSIS
Other Informa Analysis
FEATURES
Other Informa Features
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

